Squarepoint
RNAM

Squarepoint’s Avidity Biosciences RNAM Stock Holding History

Squarepoint’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,400
Closed -$845K – 4789
2025
Q3 		$845K Buy
+19,400
New +$784K ﹤0.01% 2827

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Squarepoint's RNAM Position: Q1 2026 in Review

Squarepoint sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 868,200 shares — an estimated $62.6M sold.

Squarepoint first reported a position in RNAM in Q4 2020 and held it in 14 quarters. The position peaked at $62.6M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Squarepoint reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 868,200 Avidity Biosciences shares in Q1 2026, an estimated $62.6M.
  • Squarepoint first reported a position in Avidity Biosciences in Q4 2020 and held it in 14 quarters.
  • Squarepoint's Avidity Biosciences position peaked at $62.6M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.